The following is a summary of “Survival in uveal melanoma patients is linked to genetic variation at HERC2 SNP rs12913832,” published in the September 2024 issue of Ophthalmology by Gelmi et al. Uveal ...
The investigators assessed states’ residents’ interest in the clinician via the search topic “uveal melanoma” under the Google Trends “health” category from 2014 through January 2023. The researchers ...
(RTTNews) - IDEAYA Biosciences, Inc. (IDYA) Monday announced positive interim data from a Phase 2 study evaluating darovasertib as neoadjuvant treatment for uveal melanoma (UM). Neoadjuvant therapy is ...
Ideaya Biosciences has reported positive interim Phase 2 clinical trial data for darovasertib in neoadjuvant uveal melanoma, or UM, as well as a successful Type C meeting with the Food and Drug ...